Efficiency of combined treatment of clonazepam mouthwash and vitamin B1 and alphalipoic acid supplements in the treatment of idiopathic burning mouth
Phase 3
Recruiting
- Conditions
- Idiopathic burning mouth.
- Registration Number
- IRCT20230413057893N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 54
Inclusion Criteria
Patients with healthy systemic conditions
Patients who feel oral burning more than 2 hours a day in 50% of the day and night and more than 3 months.
Exclusion Criteria
The presence of any lesions of the pharynx and nose from a clinical point of view
the use of chemical drugs
hypersensitivity reactions
physical or chemical factors
complete dental prosthesis
bad oral habits such as teeth grinding
oral mucosa disease such as lichen planus
benign migratory glossitis
bacterial, fungal and viral infections
Dry mouth primary or secondary to salivary gland disorders or after radiation therapy
neurological problems
endocrine disorders
digestive diseases
malnutrition
Pregnancy/lactation
sensitivity to clonazepam
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The degree of mouth burning. Timepoint: Day zero, fourteen and twenty eight. Method of measurement: visual analogue scaling.
- Secondary Outcome Measures
Name Time Method